Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)

被引：4

作者：

Yang, Yue ^{[1
]}

Luo, Yi-Dan ^{[1
]}

Zhang, Chen-Bo ^{[1
]}

Xiang, Yang ^{[1
,2
]}

Bai, Xin-Yue ^{[1
]}

Zhang, Die ^{[1
]}

Fu, Zhao-Ying ^{[1
]}

Hao, Ruo-Bing ^{[1
]}

Liu, Xiao-Long ^{[1
]}

机构：

[1] Yanan Univ, Sch Med, Yanan 716000, Peoples R China

[2] Yanan Univ, Coll Phys Educ, Yanan 716000, Peoples R China

来源：

ACS OMEGA | 2024年 / 9卷 / 32期

关键词：

RESPIRATORY SYNDROME-CORONAVIRUS; PAPAIN-LIKE PROTEASE; COVALENT INHIBITORS; WITHANIA-SOMNIFERA; DISCOVERY; DESIGN; AGLYCONE; BAICALIN;

D O I：

10.1021/acsomega.4c03023

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Since 2019, the novel coronavirus (SARS-CoV-2) has caused significant morbidity and millions of deaths worldwide. The Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2 and its variants, has further highlighted the urgent need for the development of effective therapeutic agents. Currently, the highly conserved and broad-spectrum nature of main proteases (M-pro) renders them of great importance in the field of inhibitor study. In this study, we categorize inhibitors targeting M-pro into three major groups: mimetic, nonmimetic, and natural inhibitors. We then present the research progress of these inhibitors in detail, including their mechanism of action, antiviral activity, pharmacokinetic properties, animal experiments, and clinical studies. This review aims to provide valuable insights and potential avenues for the development of more effective antiviral drugs against SARS-CoV-2.

引用

页码：34196 / 34219

页数：24

共 50 条

[41] Selective covalent targeting of SARS-CoV-2 main protease by enantiopure chlorofluoroacetamide
Yamane, Daiki
Onitsuka, Satsuki
Re, Suyong
Isogai, Hikaru
Hamada, Rui
Hiramoto, Tadanari
Kawanishi, Eiji
Mizuguchi, Kenji
Shindo, Naoya
Ojida, Akio
CHEMICAL SCIENCE, 2022, 13 (10) : 3027 - 3034
[42] Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
Liu, Sen
Zheng, Qiang
Wang, Zhiying
BIOINFORMATICS, 2020, 36 (11) : 3295 - 3298
[43] Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors
Khatua, Kaustav
Alugubelli, Yugendar R.
Yang, Kai S.
Vulupala, Veerabhadra R.
Blankenship, Lauren R.
Coleman, Demonta
Atla, Sandeep
Chaki, Sankar P.
Geng, Zhi Zachary
Xiao, Jing
Chen, Peng-Hsun
Cho, Chia-Chuan D.
Sharma, Shivangi
Vatansever, Erol C.
Ma, Yuying
Yu, Ge
Neuman, Benjamin W.
Xu, Shiqing
Liu, Wenshe Ray
ANTIVIRAL RESEARCH, 2024, 225
[44] Phytonutrient Inhibitors of SARS-CoV-2/NSP5-Encoded Main Protease (Mpro) Autocleavage Enzyme Critical for COVID-19 Pathogenesis
Naidu, Sreus A. G.
Tripathi, Yamini B.
Shree, Priya
Clemens, Roger A.
Naidu, A. Satyanarayan
JOURNAL OF DIETARY SUPPLEMENTS, 2023, 20 (02) : 284 - 311
[45] Design of novel and highly selective SARS-CoV-2 main protease inhibitors
Poli, Adi N. R.
Tietjen, Ian
Nandwana, Nitesh K.
Cassel, Joel
Messick, Troy E.
Register, Emery T.
Keeney, Frederick
Rajaiah, Rajesh
Verma, Atul K.
Pandey, Kabita
Acharya, Arpan
Byrareddy, Siddappa N.
Montaner, Luis J.
Salvino, Joseph M.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (10)
[46] Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations
Rudrapal, Mithun
Celik, Ismail
Khan, Johra
Ansari, Mohammad Azam
Alomary, Mohammad N.
Alatawi, Fuad Abdullah
Yadav, Rohitash
Sharma, Tripti
Tallei, Trina Ekawati
Pasala, Praveen Kumar
Sahoo, Ranjan Kumar
Khairnar, Shubham J.
Bendale, Atul R.
Zothantluanga, James H.
Chetia, Dipak
Walode, Sanjay G.
JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2022, 34 (03)
[47] Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives
Citarella, Andrea
Dimasi, Alessandro
Moi, Davide
Passarella, Daniele
Scala, Angela
Piperno, Anna
Micale, Nicola
BIOMOLECULES, 2023, 13 (09)
[48] Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease
Tan, Haozhou
Hu, Yanmei
Jadhav, Prakash
Tan, Bin
Wang, Jun
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (11) : 7561 - 7580
[49] Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors
Sobhia, M. Elizabeth
Kumar, G. Siva
Sivangula, Srikanth
Ghosh, Ketan
Singh, Harmanpreet
Haokip, Thongtinlal
Gibson, Joseph
FUTURE MEDICINAL CHEMISTRY, 2021, 13 (17) : 1435 - 1450
[50] Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
Atatreh, Noor
Mahgoub, Radwa E.
Ghattas, Mohammad A.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2025, 40 (01)

← 1 2 3 4 5 →